Day: September 21, 2023

Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST

Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST Liege, Belgium, September 21, 2023 – 5:45 pm CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces it will host a conference call to present its financial results for the six-month period ended on June 30, 2023. The call will take place on September 26 at 14:00 CEST and will be held in English. Participants can attend/register for the live webcast of the call here. A replay of the webcast will be available on the Investor Relations section of the Mithra website shortly after the close of the call. For more information, please contact: Mithra Pharmaceuticals SADavid Horn SolomonChief Executive Officerinvestorrelations@mithra.com   Investor & media relationsChris MaggosCohesion Bureauchris.maggos@cohesionbureau.com+41...

Continue reading

Information on the total number of voting rights (denominator)

Information on the total number of voting rights (denominator) Liege, Belgium, 21 September 2023 – 5:45 pm CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that, following the first, second and first part of the third drawdown by the Company under the loan facility concluded by the Company with certain funds managed by Highbridge Capital Management, LLC (“Highbridge“) and funds managed by Whitebox Advisors, LLC (“Whitebox“, and together with Highbridge, the “Lenders“), another portion of the loans was contributed in kind by Highbridge against the issuance of new shares. On 8th August 2022, the Company and the Lenders entered into a three-year term senior secured convertible facilities agreement for an amount of up to EUR 100 million, which can be drawn in three tranches. The first tranche...

Continue reading

Eramet sells its Norwegian subsidiary Eramet Titanium & Iron (“ETI”) to Ineos Enterprises for a value of $245m

Paris, 21 September 2023, 5:45 p.m. PRESS RELEASE Eramet sells its Norwegian subsidiary Eramet Titanium & Iron (“ETI”) to INEOS Enterprises for a value of $245m Following the receipt on 25 July 2023 of the unilateral offer from INEOS Enterprises for the acquisition of 100% of the shares in Eramet Titanium & Iron (“ETI”), Eramet announces that it has completed the sale of its Norwegian subsidiary today for a value of $245m. The transaction is final and subject to no condition, regulatory approvals having been obtained by INEOS Enterprises prior to the acceptance of its offer by Eramet. ETI is an ilmenite transformation plant in Norway producing titanium slag used in the pigment industry. It also produces high-purity pig iron sold to European foundries. This sale, which takes immediate effect, enables Eramet to strengthen its balance...

Continue reading

AKWEL: CURRENT OPERATING INCOME OF €30.2M IN THE FIRST HALF OF 2023

        Thursday 21 September 2023 CURRENT OPERATING INCOME OF €30.2MIN THE FIRST HALF OF 2023 2.1-point increase in the current operating margin Net income of €19.2m Benoit Coutier appointed Chief Financial Officer AKWEL (FR0000053027, AKW, PEA-eligible), the automotive and HGV equipment and systems manufacturer, published its 2023 half-yearly results, as approved by the executive board, on 18 September 2023. Audit reports are in the process of being issued. Consolidated data – in € millions 30.06.2023 30.06.2022 Var. in % Revenue 533.2 491.0 +8.6% EBITDA 49.0 42.3 +15.8% Current operating income 30.2 17.7 +70.6% Current operating margin 5.7% 3.6% +2.1 pts Operating income 30.0 17.2 +74.4% Financial income (2.5) (10.0) +77.0% Net result (group share) 19.2 1.9 – Net margin 3.6% 0.4% +3.2 pts LEVEL OF...

Continue reading

AKWEL: CURRENT OPERATING INCOME OF €30.2M FOR THE HY 2023

        Thursday 21 September 2023 CURRENT OPERATING INCOME OF €30.2MFOR THE HY 2023 AKWEL (FR0000053027, AKW), the automotive and HGV equipment and systems manufacturer, published its 2023 half-yearly results. Consolidated data – in € millions 30.06.2023 30.06.2022 Var. Revenue 533.2 491.0 +8.6% EBITDA 49.0 42.3 +15.8% Current operating income 30.2 17.7 +70.6% Current operating margin 5.7% 3.6% +2.1 pts Operating income 30.0 17.2 +74.4% Financial income (2.5) (10.0) +77.0% Net result (group share) 19.2 1.9 – Net margin 3.6% 0.4% +3.2 pts Continued growth in business volumes, combined with better control of costs and sales prices, have led to a return to a more significant level of profitability. Pressures on costs remain high, however, particularly on the wage bill. Gross operating surplus was up by 15.8%...

Continue reading

Global Web 3.0 Market Size to Reach USD 81.5 Billion in 2030 | Emergen Research

Rising demand for enhanced user experience and increasing advancements in connectivity are factors driving market revenue growth Vancouver, Sept. 21, 2023 (GLOBE NEWSWIRE) — The global Web 3.0 market size reached USD 3.2 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the forecast period, according to latest analysis by Emergen Research. Rising demand for more user-oriented, interactive, advanced, and secured technologies, and increasing initiatives by governments of various countries for development of newer technologies such as Web 3.0 to enable better transparency to users are some major factors expected to drive global Web 3.0 market revenue growth to a significant extent during the forecast period. Increasing preference and use of Non-Fungible Tokens (NFTs) as well as digital collectibles,...

Continue reading

LSL Pharma Group Announces Brokered Private Placement of Convertible Debentures of Up to $4,000,000

Debenture proceeds will provide additional funds and flexibility for growth BOUCHERVILLE, Québec, Sept. 21, 2023 (GLOBE NEWSWIRE) — LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announced today that it has entered into an agreement with iA Capital Markets as the sole agent and sole bookrunner (“Agent”), in connection with a “best-efforts” brokered private placement offering of up to $4.0 million in unsecured convertible debentures (the “Debentures”) of the Company at a price of $10 per convertible debenture, to raise aggregate gross proceeds between $2.0 million and $4.0 million (the “Offering“). The Debentures will be convertible into Class A shares of the capital stock of the Company (the “Class A Shares”) at the option of the holder...

Continue reading

Global Light Therapy Market Size to Reach USD 1.70 Billion in 2030 | Emergen Research

Rapid development and innovation in light therapy technologies and growing patient’s preference toward non-invasive procedures are key factors driving market revenue growth Vancouver, Sept. 21, 2023 (GLOBE NEWSWIRE) — The global light therapy market size was USD 1.10 Billion in 2021 and is expected to register a revenue CAGR of 5.1% during the forecast period, according to the latest analysis by Emergen Research. Technological advancements in light therapy and launch of innovative products, such as handheld light therapy devices, are factors projected to support market revenue growth between 2021 and 2030.  For example, Body Balance System, a Las Vegas-based company makes zero-gravity beds filled with small red lights or diodes due to its health and skin benefits such as fat loss, pain relief, muscle recovery after a workout, and...

Continue reading

Devon Energy Schedules Third-Quarter 2023 Earnings Release and Conference Call

OKLAHOMA CITY, Sept. 21, 2023 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) today announced it will report third-quarter 2023 results on Tuesday, Nov. 7, after the close of U.S. financial markets. The earnings release and presentation for the third-quarter 2023 results will be available on the company’s website at www.devonenergy.com. On Wednesday, Nov. 8, the company will hold a conference call at 10:00 a.m. Central Time (11:00 a.m. Eastern Time), which will consist primarily of answers to questions from analysts and investors. A webcast link to the conference call will be provided on Devon’s website at www.devonenergy.com. A replay will be available on the website following the call. ABOUT DEVON ENERGY Devon Energy is a leading oil and gas producer in the U.S. with a premier multi-basin portfolio headlined by a world-class...

Continue reading

WithSecure launches a new plan period for 2024-2026 within the Employee Share Savings Plan

WithSecure Corporation, Stock Exchange release (Other information disclosed according to the rules of the Exchange), 21 September 2023 at 17:00 EEST WithSecure launches a new plan period for 2024-2026 within the Employee Share Savings Plan In 2022, WithSecure took into use an Employee Share Savings Plan (ESSP), based on which the Board of Directors can decide on annually commencing plan periods. Each plan period includes a 12-month savings period and a two-year holding period following the savings period. The Board of Directors of WithSecure Corporation has decided to launch a new Plan period 2024-2026 within the ESSP for the employees of WithSecure Corporation and its subsidiaries. The aim of the ESSP is to encourage employees to acquire and own WithSecure shares, and it is intended to align the interests of the shareholders and the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.